Hello, myeloma world. It's too late to wish you a good morning, but we do hope you had a nice day.

We were right on the mark yesterday when we worried about a “tidal wave” of new myeloma-related research hitting sometime soon. The wave has hit. Today's list of new research studies – see the bottom of this article – may be longer than it's ever been.

Processing that list has taken quite a bit of time, and we …

Good morning, myeloma world.

Have you ever gone for a walk on a hot summer day, with birds singing and insects buzzing and the sound of children and traffic in the distance, and all of a sudden you notice that all of the sounds that were there before aren't there any more, and it's really, really quiet? Like, scary quiet?

Well, that's how we feel right now here at Myeloma Morning Headquarters, be­cause we don't have a single new myeloma-related …

Good morning, myeloma world.

It's another rainy day here at Myeloma Morning Headquarters, and we're trying to stay positive by keeping in mind that old rhyme, “April showers bring May flowers.”

“Rain is good,” we keep telling ourselves. “Rain is good.”

But we're not so sure, so we're turning our attention to our main task today, which is getting you up to speed on what's new in myeloma world.

In that regard, we'll be focusing first on a brief study …

Good morning, myeloma world.

It's Monday, and the weekend definitely is over. The vigorous activity in our email inbox is making that eminently clear. But, with the week still so young, there isn't much new myeloma research for us to review with you. In fact, we have just two new studies that we'd like to discuss today.

Both studies are by European researchers who have compiled and analyzed retrospective data on some important topics.

One study out of Portugal looks …

Good morning, myeloma world.

It's a Sunday, so it probably won't be too much of a surprise that today's list of new multiple myeloma-related research is rather short.

In fact, a quick check of our usual list of new multiple myeloma research – which we include at the end of every edition of Myeloma Morning – reveals that there are just three new studies.

We'll spend most of our time in today's report looking at a European …

Good morning, myeloma world.

As we were finalizing today's edition of Myeloma Morning, we were suddenly reminded of how inter­na­tional the field of multiple myeloma research truly is.

The first research study we review below is by a team of German researchers. We also discuss two studies by Korean researchers, and a topic sparked by a report written by Chinese researchers. At the end of today's report, the list of new myeloma research articles also in­cludes publications …

Good morning, myeloma world.

There are times when we write an edition of Myeloma Morning, and it turns out completely different than expected. Today's edition is a perfect example.

As we were planning today's report, we thought it would focus on two preclinical research studies examining the potential new myeloma therapies CCF642 and BDA-366.

And, yes, we do start today's report with summaries of those two studies.

But readers will be making a mistake if they stop …